Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Methylnaltrexone in Opioid-Induced Bowel Dysfunction
NCT01367574Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Apr 2002
- Primary completion
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylnaltrexone in opioid-induced constipation (OIC), sponsored by Valeant Pharmaceuticals. Started Apr 2002; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT01367574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01367574.